Co-Diagnostics, Inc. (CODX)
USD 0.32
(-9.78%)
USD 0.32
(-9.78%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -41.47 Million USD | -1663.77% |
| 2022 | -10.3 Million USD | -105.77% |
| 2021 | 46.4 Million USD | 8.75% |
| 2020 | 41.83 Million USD | 808.95% |
| 2019 | -6.02 Million USD | 1.02% |
| 2018 | -6.08 Million USD | -34.32% |
| 2017 | -6.6 Million USD | -174.52% |
| 2016 | -1.65 Million USD | 14.25% |
| 2015 | -1.92 Million USD | -88.57% |
| 2014 | -1.02 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -9.83 Million USD | 26.06% |
| 2024 Q1 | -10.14 Million USD | 13.75% |
| 2023 FY | - USD | -1663.77% |
| 2023 Q1 | -11.09 Million USD | -368.26% |
| 2023 Q2 | -12.45 Million USD | -12.35% |
| 2023 Q3 | -9.2 Million USD | 26.14% |
| 2023 Q4 | -11.51 Million USD | -25.1% |
| 2022 Q2 | -4.48 Million USD | -166.13% |
| 2022 FY | - USD | -105.77% |
| 2022 Q4 | 4.13 Million USD | 145.36% |
| 2022 Q3 | -9.11 Million USD | -103.12% |
| 2022 Q1 | 6.78 Million USD | -34.83% |
| 2021 Q1 | 10.4 Million USD | -34.45% |
| 2021 FY | - USD | 8.75% |
| 2021 Q4 | 10.41 Million USD | -24.14% |
| 2021 Q3 | 13.72 Million USD | 15.69% |
| 2021 Q2 | 11.86 Million USD | 14.05% |
| 2020 Q3 | 12.85 Million USD | 1.51% |
| 2020 FY | - USD | 808.95% |
| 2020 Q4 | 15.86 Million USD | 23.48% |
| 2020 Q2 | 12.66 Million USD | 1312.21% |
| 2020 Q1 | -1.04 Million USD | 39.13% |
| 2019 Q1 | -1.24 Million USD | 32.44% |
| 2019 Q4 | -1.71 Million USD | 0.86% |
| 2019 Q2 | -1.32 Million USD | -6.34% |
| 2019 Q3 | -1.73 Million USD | -30.3% |
| 2019 FY | - USD | 1.02% |
| 2018 Q3 | -1.57 Million USD | -20.07% |
| 2018 FY | - USD | -34.32% |
| 2018 Q1 | -1.29 Million USD | 13.11% |
| 2018 Q2 | -1.31 Million USD | -1.37% |
| 2018 Q4 | -1.84 Million USD | -17.05% |
| 2017 Q4 | -1.49 Million USD | 16.67% |
| 2017 Q1 | -554.63 Thousand USD | -27.05% |
| 2017 FY | - USD | -174.52% |
| 2017 Q3 | -1.79 Million USD | -159.85% |
| 2017 Q2 | -689.86 Thousand USD | -24.38% |
| 2016 Q3 | -385.05 Thousand USD | -0.95% |
| 2016 Q1 | -447.43 Thousand USD | -2.71% |
| 2016 FY | - USD | 14.25% |
| 2016 Q4 | -436.55 Thousand USD | -13.37% |
| 2016 Q2 | -381.43 Thousand USD | 14.75% |
| 2015 FY | - USD | -88.57% |
| 2015 Q4 | -435.61 Thousand USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -207.524% |
| Cerus Corporation | -26.53 Million USD | -56.3% |
| OrthoPediatrics Corp. | -8.38 Million USD | -394.878% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -295.215% |
| Talis Biomedical Corporation | -66.04 Million USD | 37.201% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -148.73% |
| Inogen, Inc. | -45.67 Million USD | 9.202% |
| Spectral AI, Inc. | -12.26 Million USD | -238.246% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 13.036% |
| CVRx, Inc. | -38.73 Million USD | -7.087% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1075.617% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -242.577% |
| Orthofix Medical Inc. | -86.98 Million USD | 52.318% |
| Venus Concept Inc. | -26.11 Million USD | -58.832% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 16.667% |
| Bioventus Inc. | -23.07 Million USD | -79.782% |
| BrainsWay Ltd. | -2.31 Million USD | -1694.711% |
| Envoy Medical, Inc. | -18.23 Million USD | -127.414% |
| electroCore, Inc. | -17.76 Million USD | -133.535% |
| IceCure Medical Ltd | -15.25 Million USD | -171.919% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 16.633% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -146.064% |
| MaxCyte, Inc. | -44.12 Million USD | 6.01% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -252.806% |
| Nexalin Technology, Inc. | -5.69 Million USD | -628.662% |
| PAVmed Inc | -75.74 Million USD | 45.241% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 22.847% |
| RxSight, Inc. | -41.03 Million USD | -1.069% |
| Sight Sciences, Inc. | -49.41 Million USD | 16.066% |
| SI-BONE, Inc. | -34.44 Million USD | -20.408% |
| TELA Bio, Inc. | -40.63 Million USD | -2.074% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 28.856% |
| Treace Medical Concepts, Inc. | -39 Million USD | -6.326% |
| LivaNova PLC | 39.01 Million USD | 206.304% |
| 908 Devices Inc. | -34.02 Million USD | -21.898% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 62.497% |
| Nemaura Medical Inc. | -7.28 Million USD | -469.17% |
| NeuroPace, Inc. | -22.83 Million USD | -81.64% |
| LENSAR, Inc. | -8.71 Million USD | -375.967% |
| Apyx Medical Corporation | -18.11 Million USD | -128.996% |
| Cutera, Inc. | -136.56 Million USD | 69.628% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -1127.093% |
| BioSig Technologies, Inc. | -28.15 Million USD | -47.333% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1748.48% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -97.607% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 110.813% |
| Axonics, Inc. | 7.77 Million USD | 633.45% |
| Outset Medical, Inc. | -153.78 Million USD | 73.031% |
| IRIDEX Corporation | -7.44 Million USD | -456.871% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 57.719% |
| IRadimed Corporation | 20.8 Million USD | 299.397% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -414.46% |
| INVO Bioscience, Inc. | -6.88 Million USD | -502.843% |
| Telesis Bio, Inc. | -40.49 Million USD | -2.427% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 213.084% |
| Varex Imaging Corporation | 67.2 Million USD | 161.72% |
| Quipt Home Medical Corp. | 44.07 Million USD | 194.111% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -281.562% |
| Pulmonx Corporation | -55.09 Million USD | 24.715% |
| Dynatronics Corporation | -976 Thousand USD | -4149.531% |
| Modular Medical, Inc. | -17.1 Million USD | -142.506% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -186.336% |
| Semler Scientific, Inc. | 23.58 Million USD | 275.827% |
| InMode Ltd. | 196.28 Million USD | 121.131% |
| Bruker Corporation | 599 Million USD | 106.924% |
| Cytosorbents Corporation | -28.81 Million USD | -43.959% |
| DexCom, Inc. | 916.7 Million USD | 104.524% |
| Align Technology, Inc. | 799.03 Million USD | 105.191% |
| Viveve Medical, Inc. | -20.61 Million USD | -101.173% |
| ZimVie Inc. | 91.07 Million USD | 145.541% |
| Movano Inc. | -29.12 Million USD | -42.406% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -840.92% |
| Nexalin Technology, Inc. | -5.69 Million USD | -628.662% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1075.617% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 78.693% |
| Profound Medical Corp. | -27.12 Million USD | -52.915% |
| Insulet Corporation | 323.6 Million USD | 112.817% |
| enVVeno Medical Corporation | -25.01 Million USD | -65.784% |
| Surmodics, Inc. | 1.18 Million USD | 3591.226% |
| iCAD, Inc. | -6.56 Million USD | -531.771% |
| Nuwellis, Inc. | -16.35 Million USD | -153.581% |
| Biotricity, Inc. | -8.82 Million USD | -369.806% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 57.181% |
| Aethlon Medical, Inc. | -11.84 Million USD | -250.032% |
| InspireMD, Inc. | -20.91 Million USD | -98.344% |
| PAVmed Inc. | -75.74 Million USD | 45.241% |
| BIOLASE, Inc. | -15.13 Million USD | -173.966% |
| Beyond Air, Inc. | -59.03 Million USD | 29.739% |
| FONAR Corporation | 28.25 Million USD | 246.809% |
| AxoGen, Inc. | -13.32 Million USD | -211.193% |
| Vivani Medical, Inc. | -26.6 Million USD | -55.877% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 269.006% |
| Inari Medical, Inc. | 7.11 Million USD | 683.098% |
| UFP Technologies, Inc. | 72.74 Million USD | 157.017% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -1124.997% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -573.746% |
| Tenon Medical, Inc. | -15.52 Million USD | -167.103% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -171.687% |
| AdaptHealth Corp. | -171.09 Million USD | 75.758% |
| Sintx Technologies, Inc. | -6.6 Million USD | -528.421% |
| NanoVibronix, Inc. | -3.43 Million USD | -1107.446% |
| Quanterix Corporation | -38.08 Million USD | -8.895% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -281.562% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 138352.533% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 85.042% |
| TransMedics Group, Inc. | -7.6 Million USD | -445.518% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -90.562% |
| NeuroMetrix, Inc. | -7.09 Million USD | -484.511% |
| Hyperfine, Inc. | -47.06 Million USD | 11.868% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 28.867% |
| Biomerica, Inc. | -5.99 Million USD | -592.07% |
| Bone Biologics Corporation | 479.57 Thousand USD | 8748.495% |
| AVITA Medical, Inc. | -39.56 Million USD | -4.822% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -352.154% |
| Silk Road Medical, Inc | -45.08 Million USD | 7.995% |